Bronchial thermoplasty in asthma.
In this review we discuss the potential of a new procedure, termed Bronchial Thermoplasty to prevent serious consequences resulting from excessive airway narrowing. The most important factor in minimizing an asthmatic attack is limiting the degree of smooth muscle shortening. The premise that airway smooth muscle can be either inactivated or obliterated without any long-term alteration of other lung tissues, and that airway function will remain normal, albeit with reduced bronchoconstriction, has now been demonstrated in dogs, a subset of normal subjects, and mild asthmatics. Bronchial Thermoplasty may thus develop into a useful clinical procedure to effectively impair the ability for airway smooth muscle to reach the levels of pathologic narrowing that characterizes an asthma attack. It may also enable more successful treatment of asthma patients who are unresponsive to more conventional therapies. Whether this will remain stable for the lifetime of the patient still remains to be determined, but at the present time, there are no indications that the smooth muscle contractility will return. This successful preliminary experience showing that Bronchial Thermoplasty could be safely performed in patients with asthma has led to an ongoing clinical trial at a number of sites in Europe and North America designed to examine the effectiveness of this procedure in subjects with moderately severe asthma.
Mitzner
Wayne
W
Department of Environmental Health Sciences, Johns Hopkins University, MD 21204, USA. wmitzner@jhsph.edu
D000818:Animals; D001249:Asthma / Q000503:physiopathology / Q000601:surgery* / Q000628:therapy*; D016535:Bronchial Hyperreactivity / Q000503:physiopathology / Q000601:surgery* / Q000628:therapy*; D001999:Bronchoscopy; D017115:Catheter Ablation; D006358:Hot Temperature / Q000627:therapeutic use*; D006801:Humans